News | November 24, 2014

Gamma Medica to Now Offer Philips MicroDose SI for a More Comprehensive Breast Cancer Solution

LumaGEM and MicroDose SI will bolster breast imaging suites’ screening offering in North America

Gamma Medica announced the company now offers Philips MicroDose SI, the first full-field digital mammography (FFDM) system that supports single-shot, non-invasive spectral imaging, as a complement to its market leading LumaGEM Molecular Breast Imaging (MBI) system. LumaGEM is a highly effective and cost-efficient technology for detecting breast cancer in patients with complex mammograms and dense breast tissue. The agreement with Philips will enable Gamma Medica to provide breast imaging suites with the option to purchase both technologies and offer the most advanced and safest commercially available dense breast solution for women. Philips will continue selling MicroDoseSI directly to customers.

Philips MicroDose mammography SI delivers outstanding image quality and non-invasive spectral applications in one fast and comfortable low-dose mammogram.

For those 40 percent of U.S. women who have dense breast tissue and those who have received inconclusive mammography results, the LumaGEM used as a secondary imaging tool is highly sensitive in its ability to detect lesions as small as five millimeters. As a functional imaging modality, it is also highly specific, resulting in fewer “false positives” and higher true positive biopsy rates compared to anatomical imaging methods such as ultrasound and MRI.

Breast tissue density has been linked to an increased risk of breast cancer and also decreases the sensitivity of mammography which impacts early detection.  Thirty-five percent of breast cancer goes undetected by mammography in women with dense breasts, as dense tissue masks the appearance of tumors.

“Gamma Medica is very excited to be working closely with Philips in an effort to provide women with the best technology options for breast cancer screening. Together, the LumaGEM and Philips MicroDose SI are the solution for increasing patient satisfaction and improving patient outcomes while lowering the overall cost of breast cancer treatment,” said Jim Calandra, president and chief executive officer of Gamma Medica. “The opportunity for imaging suites to have two leading breast cancer detection technologies under one roof will help revolutionize the future of breast cancer care.”

“Like Philips, Gamma Medica has taken a proactive approach to the growing industry demand and increasing regulatory pressure for low dose solutions,” said Richard Fabian, vice president, Imaging Systems Marketing, of Philips Healthcare. “MicroDose SI is just one of a range of Philips low-dose solutions that provide clinicians with the data and insights they need to make a definitive diagnosis while avoiding unnecessary exposure to radiation.”

For more information: www.gammamedia.com

Related Content

Clinical Trial Testing Topical Gel to Reduce Breast Density
News | Breast Density | June 19, 2018
Women with dense breast tissue soon might be adding a new product to their skincare routine to help them fight breast...
California Women In Favor of Extending State's Breast Density Inform Law
News | Breast Density | June 15, 2018
A recent survey of California women found that 95 percent of respondents want the state’s breast density inform law to...
Women More Likely to Use Other Preventive Health Services Following Mammography
News | Mammography | June 13, 2018
Medicare beneficiaries who undergo breast cancer screening with mammography are more likely than unscreened women to...
How AI and Deep Learning Will Enable Cancer Diagnosis Via Ultrasound

The red outline shows the manually segmented boundary of a carcinoma, while the deep learning-predicted boundaries are shown in blue, green and cyan. Copyright 2018 Kumar et al. under Creative Commons Attribution License.

News | Ultrasound Imaging | June 12, 2018 | Tony Kontzer
June 12, 2018 — Viksit Kumar didn’t know his mother had...
Breast imaging technologies have seen a rapid evolution.

Breast imaging technologies have seen a rapid evolution.

Feature | Women's Health | June 05, 2018 | By Jeff Zagoudis
Breast imaging technologies have evolved rapidly in the last two decades to help physicians detect breast cancers at
Breast Cancer Survivors Not Getting Recommended Number of Mammograms Post-Surgery
News | Mammography | May 24, 2018
Breast cancer survivors are not getting the recommended level of screening post-surgery, according to a newly-published...
Breast Cancer Places Greater Financial Burden on Black Women
News | Women's Health | May 16, 2018
Having breast cancer placed a significantly greater financial strain on black women than white women, according to a...
FDA's MQSA Accreditation Bodies Approved for Tomosynthesis Accreditation

Image courtesy of Fujifilm.

Feature | Mammography | May 14, 2018
On April 9, 2018, the U.S. Food and Drug Administration (FDA) announced that all four of its Mammography Quality...
Overlay Init